Stockreport

Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m [Yahoo! Finance]

ASAHI KAISEI CRP UNSP/ADR  (AHKSY) 
NASDAQ:AMEX Investor Relations: asahi-kasei.co.jp/asahi/en/ir
PDF The acquisition will expand the company's speciality pharmaceutical platform into severe infectious diseases. Completion is expected in the first quarter of fiscal 2026 [Read more]